| 000 | 02564nas a22003495i 4500 | ||
|---|---|---|---|
| 001 | 2365-421X | ||
| 003 | DE-He213 | ||
| 005 | 20200124155122.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 150810s||||||||gw uu poo|||||| b|EN |d | ||
| 022 | _a2365-421X | ||
| 024 | 7 |
_a41181 _2local |
|
| 210 | 1 | 0 | _aEJNMMI radiopharm. chem. |
| 245 | 1 | 0 |
_aEJNMMI Radiopharmacy and Chemistry _h[electronic resource] / _cedited by Philip Elsinga. |
| 264 | 1 |
_aCham : _bSpringer International Publishing : _bImprint: Springer. |
|
| 300 | _bonline resource. | ||
| 520 | _aEJNMMI Radiopharmacy and Chemistry publishes new research in the field of development of new imaging and radionuclide-based therapeutic agents for application in nuclear medicine and molecular imaging. The journal provides a platform for chemists, pharmacists and basic scientists to present their views and scientific work. In addition, the journal provides insight into novel concepts of imaging or radionuclide-based therapeutic agent applications of relevance for the whole molecular imaging community. The journal reports original research articles, review papers, guidelines on the application of imaging or radionuclide therapy agents, editorials, and letters to the editor. Research articles on novel radiochemistry, new radiopharmaceuticals including their first biological evaluation, molecular imaging agents including optical imaging, MRI, and hybrid probes, are the main focus of the journal. To translate imaging and radionuclide therapy agents to the clinic, legislative issues related to their production and safety can be presented as well in the form of guidelines or position papers. | ||
| 650 | 0 | _aMolecular biology. | |
| 650 | 0 | _aNuclear chemistry. | |
| 650 | 0 | _aRadiology. | |
| 650 | 0 | _aNuclear medicine. | |
| 650 | 0 | _aPharmacotherapy. | |
| 650 | 1 | 4 |
_aNuclear Medicine. _0http://scigraph.springernature.com/things/product-market-codes/H29048 |
| 650 | 2 | 4 |
_aImaging / Radiology. _0http://scigraph.springernature.com/things/product-market-codes/H29005 |
| 650 | 2 | 4 |
_aNuclear Chemistry. _0http://scigraph.springernature.com/things/product-market-codes/C31000 |
| 650 | 2 | 4 |
_aPharmacotherapy. _0http://scigraph.springernature.com/things/product-market-codes/H69000 |
| 650 | 2 | 4 |
_aMolecular Medicine. _0http://scigraph.springernature.com/things/product-market-codes/B1700X |
| 700 | 1 |
_aElsinga, Philip. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 856 | 4 | 0 |
_uhttp://link.springer.com/journal/41181 _zOpen Access |
| 999 |
_c513726 _d513724 |
||